All News

2018

December

Media Release / Dec 21, 2018

Novartis receives European Commission (EC) approval for expanded indication for Kisqali® (ribociclib)

Read More
Media Release / Dec 20, 2018

Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies

Read More
Media Release / Dec 20, 2018

Novartis announces new CEO of Oncology Business Unit

Read More
Media Release / Dec 19, 2018

Sandoz enters into commercialization and supply agreement for insulin biosimilars, anticipating growing demand as diabetes burden rises

Read More
Media Release / Dec 19, 2018

Alcon Announces Acquisition of Tear Film Innovations, Inc.

Read More
Media Release / Dec 13, 2018

Novartis receives European Commission approval for self-administration of Xolair® across all indications

Read More
Thierry Diagana, Head of the Novartis Institute for Tropical Diseases (NITD) at NITD headquarters California, USA
Story / Dec 12, 2018

Bringing real change to people

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Read More
President of Advanced Accelerator Applications shares her story for “Women in Science.”
Story / Dec 12, 2018

Women in Science: Susanne Schaffert

Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.

Read More
Media Release / Dec 10, 2018

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder

Read More
Story / Dec 10, 2018

The changing landscape of cancer treatment

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More